GeoPharma Financial Statements
GeoPharma Financial Information
| Company Type | Public Headquarters |
|---|---|
| Fiscal Year-End | March |
GeoPharma Income Statement
| 2008 | 2007 | 2006 | |
|---|---|---|---|
| Revenue ($ mil.) | 55.0 | 59.8 | 49.7 |
| Gross Profit ($ mil.) | 10.9 | 16.9 | 12.5 |
| Operating Income ($ mil.) | (9.9) | 1.3 | 2.0 |
| Total Net Income ($ mil.) | (7.0) | 2.5 | 1.8 |
| Diluted EPS (Net Income) | (0.59) | 0.19 | 0.14 |
GeoPharma Quarterly Statements
| Quarter Ending Sep 08 | Quarter Ending Jun 08 | Quarter Ending Mar 08 | |
|---|---|---|---|
| Revenue ($ mil.) | 16.0 | 20.0 | 23.9 |
| Gross Profit ($ mil.) | 2.7 | 3.7 | 4.6 |
| Operating Income ($ mil.) | (4.4) | (3.0) | (2.8) |
| Total Net Income ($ mil.) | (3.8) | (2.6) | (2.7) |
| Diluted EPS (Net Income) | (0.24) | (0.19) | (0.20) |
GeoPharma Stock Quote & Chart
| 11/21/08 15:37:33 EST •
NASDAQ •
0.44
•
|
|---|
|
Quotes delayed 15 minutes for NASDAQ. 20 minutes for NYSE and AMEX. Market Data provided by Interactive Data. Powered and Implemented by Interactive Data Managed Solutions.
|
GeoPharma Financial Ratios
| Company | Industry Median |
Market Median1 |
|
|---|---|---|---|
| Price/Sales Ratio | 0.12 | 2.02 | 0.82 |
| Price/Earnings Ratio | -- | 8.65 | 9.00 |
| Price/Book Ratio | 0.25 | 1.45 | 0.79 |
| Price/Cash Flow Ratio | -- | 7.52 | 5.08 |
1 Public companies trading on the New York Stock Exchange, the American Stock Exchange, and the NASDAQ National Market.
Detailed GeoPharma Financial Ratios
GeoPharma Competitive Intelligence
| NAI | NBTY | Nexgen | |
|---|---|---|---|
| Annual Sales ($ mil.) | 81.8 | 2,014.5 | 59.8 |
| Employees | -- | 10,800 | 210 |
| Market Cap ($ mil.) | 43.7 | 1,116.3 | -- |
Competitive Landscape





